Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Aliment Pharmacol Ther. 2019 Jan 20;49(4):389–397. doi: 10.1111/apt.15077

Figure 3.

Figure 3.

Adequate relief of IBS and change in pain scores ≥30 at week 12.

a. A greater proportion of subjects receiving pregabalin reported adequate relief of IBS compared to subjects receiving placebo (p>0.05)

b. A trend was seen where a greater percentage of the pregabalin treatment arm had at least a 30-point improvement in their abdominal pain scores compared with the placebo arm.

Not adjusted for age and gender